The weekly litigation news digest is live. Subscribe now

IP Verse

Targeted/Immunomodulatory Fusion Proteins And Methods For Making Same - EP2844667

The patent EP2844667 was granted to Biocon on May 30, 2018. The application was filed on Mar 13, 2013 under application number EP13734158A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2844667

BIOCON
Application Number
EP13734158A
Filing Date
Mar 13, 2013
Status
Opposition Rejected
Mar 31, 2023
Publication Date
May 30, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOFFMANN EITLEFeb 28, 2019HOFFMANN EITLEADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2009039409
INTERNATIONAL-SEARCH-REPORTWO2009114110
INTERNATIONAL-SEARCH-REPORTWO2011109789
INTERNATIONAL-SEARCH-REPORTWO9833914
OPPOSITIONWO0158957
OPPOSITIONWO2009027471
OPPOSITIONWO2011109789

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents